Interferon (IFN)-alpha 2b is used for adjuvant therapy in malignant melanoma. Neurotoxicity as a side effect has been well described. Resting and action tremor related to interferon have been reported but are relatively uncommon. We report a case of a delayed-onset interferon-related action tremor in a patient with malignant melanoma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.coc.0000145982.86749.b4 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!